Bendamustine-Rituximab in Young CLL: Relevance in the Era of Small Molecule Inhibitors.

Published in: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion (2022)

Our results show that BR chemotherapy can safely and effectively be used in upfront treatment of young CLL patients and provide durable responses.

Keyphrases